Toshiba will continue offering Vital Images' Vitrea 2 software through subsidiaries and distributors in more than 50 countries under a renewed agreement announced Jan. 9. Toshiba has been offering the software as the 3D medical imaging product of choice
Toshiba will continue offering Vital Images' Vitrea 2 software through subsidiaries and distributors in more than 50 countries under a renewed agreement announced Jan. 9. Toshiba has been offering the software as the 3D medical imaging product of choice to customers purchasing its Aquilion multidetector CTs. The new agreement includes a minimum worldwide revenue commitment from Toshiba of more than $5 million and is effective through Sept. 30, 2003. It can be renewed with the mutual consent of Vital Images and Toshiba.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.